Axsome Therapeutics, Inc. (AXSM) stock analysis
In our weekly check, Axsome Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 2, red flags: 8.
About Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as AXSM.
What our checks show for AXSM
Red flags
- The company has an operating loss, so it does not cover the interest bill: interest is paid from cash or new debt.
- The net margin fell by 18.2 points over 5 years, to -18.2%: the company keeps less of each sale as profit.
- Earnings per share fell 12.7% a year over the last 3 years.
- The company is losing money: the net margin is -18.2%.
- Free cash flow is negative (-9.5% of revenue): the business spends more cash than it brings in.
- The stock has fallen as much as 87% from a peak. Would you have held through that?
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- The price swings a lot: 43.5% annual volatility. Expect large ups and downs.
Strengths
- Debt is low: 2.07x equity.
- The gross margin is 93.2% and has risen by 93.2 points: pricing power is holding.
- Analysts expect earnings per share to grow about 71.6% a year over the next years.
- Analysts expect revenue to grow about 46.9% a year over the next years.
- Analysts expect the net margin to improve by 47.5 points from today's -18.2%.
- Revenue grew 159% a year over the last 3 years.
Similar companies
TWST · ABVX · ORKA · CYTK · IMVT · TXG
Questions
What grade does Axsome Therapeutics, Inc. (AXSM) have?
In our weekly check, Axsome Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 2, red flags: 8. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of AXSM stock?
This week's biggest flags for Axsome Therapeutics, Inc.: Weak interest cover, Margins falling, Weak EPS growth. In total 10 of 22 checks show a warning or a red flag.
What does Axsome Therapeutics, Inc. do?
Axsome Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as AXSM.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis